Add like
Add dislike
Add to saved papers

Association of ADC of hyperintense lesions on FLAIR images with TERT promoter mutation status in glioblastoma IDH wild type.

BACKGROUND: Although mutations in telomerase reverse transcriptase ( TERT ) promoter ( TERT p) are the most common alterations in glioblastoma (GBM), predicting TERT p mutation status by preoperative imaging is difficult. We determined whether tumour-surrounding hyperintense lesions on fluid-attenuated inversion recovery (FLAIR) were superior to those of contrast-enhanced lesions (CELs) in assessing TERT p mutation status using magnetic resonance imaging (MRI).

METHODS: This retrospective study included 114 consecutive patients with primary isocitrate dehydrogenase (IDH)-wild-type GBM. The apparent diffusion coefficient (ADC) and volume of CELs and FLAIR hyperintense lesions (FHLs) were determined, and the correlation between MRI features and TERT p mutation status was analyzed. In a subset of cases, FHLs were histopathologically analyzed to determine the correlation between tumor cell density and ADC.

RESULTS: TERT p mutations were present in 77 (67.5%) patients. The minimum ADC of FHLs was significantly lower in the TERT p-mutant group than in the TERT p-wild-type group (mean, 958.9 × 10-3 and 1092.1 × 10-3 mm2 /s, respectively, P < 0.01). However, other MRI features, such as CEL and FHL volumes, minimum ADC of CELs, and FHL/CEL ratio, were not significantly different between the two groups. Histopathologic analysis indicated high tumor cell density in FHLs with low ADC.

CONCLUSION: The ADC of FHLs was significantly lower in IDH-wild-type GBM with TERT p mutations, suggesting that determining the ADC of FHLs on preoperative MRI might be helpful in predicting TERT p mutation status and surgical planning.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app